Invention Grant
- Patent Title: Tamper resistant dosage form comprising co-extruded, adverse agent particles and process of making same
-
Application No.: US15419486Application Date: 2017-01-30
-
Publication No.: US10039720B2Publication Date: 2018-08-07
- Inventor: Benjamin Oshlack , Hua-Pin Huang
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: PURDUE PHARMA L.P.
- Current Assignee: PURDUE PHARMA L.P.
- Current Assignee Address: US CT Stamford
- Agency: Lowenstein Sandler LLP
- Main IPC: A61K9/50
- IPC: A61K9/50 ; A61K31/485 ; A61K9/00 ; A61K9/48
Abstract:
The present invention relates to co-extruded pharmaceutical compositions and dosage forms comprising an adverse agent, such as an opioid antagonist, which can be sequestered. The pharmaceutical compositions and dosage forms diversion of a dosage form containing an active pharmaceutical agent, such as an opioid. The present invention also relates to methods of treating a patient with such a dosage form, as well as kits containing such a dosage form with instructions for using the dosage form to treat a patient. The present invention further relates to a process for the preparation of such pharmaceutical compositions and dosage forms comprising co-extrusion of a core comprising an adverse agent and a sheath.
Public/Granted literature
- US20170135959A1 TAMPER RESISTANT DOSAGE FORM COMPRISING CO-EXTRUDED, ADVERSE AGENT PARTICLES AND PROCESS OF MAKING SAME Public/Granted day:2017-05-18
Information query
